Organovo Holdings, Inc. financial data

Symbol
ONVO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
11555 Sorrento Valley Road, Suite 100, San Diego, CA
State of incorporation
DE
Fiscal year end
March 31
Former names
REAL ESTATE RESTORATION & RENTAL, INC. (to 10/31/2011)
Latest financial report
10-Q - Q2 2024 - Aug 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 358 % -60.7%
Debt-to-equity 44 % +140%
Return On Equity -225 % -131%
Return On Assets -156 % -90%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15.4M shares +76.3%
Common Stock, Shares, Outstanding 14.4M shares +64.9%
Entity Public Float 10.3M USD -38.2%
Common Stock, Value, Issued 14K USD +55.6%
Weighted Average Number of Shares Outstanding, Basic 14.7M shares +68.2%
Weighted Average Number of Shares Outstanding, Diluted 14.7M shares +68.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 73K USD -83.6%
Research and Development Expense 5.23M USD -45.1%
Costs and Expenses 14.4M USD -25%
Operating Income (Loss) -14.3M USD +23.6%
Nonoperating Income (Expense) 292K USD -52.7%
Income Tax Expense (Benefit) 2K USD 0%
Net Income (Loss) Attributable to Parent -14M USD +22.6%
Earnings Per Share, Basic -1.37 USD/shares +33.8%
Earnings Per Share, Diluted -1.37 USD/shares +33.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.19M USD -42.5%
Accounts Receivable, after Allowance for Credit Loss, Current 48K USD -67.8%
Inventory, Net 408K USD
Other Assets, Current 4K USD -94.2%
Assets, Current 7.28M USD -37.7%
Property, Plant and Equipment, Net 601K USD -29.3%
Operating Lease, Right-of-Use Asset 1.19M USD -25.7%
Assets 9.47M USD -35.8%
Accounts Payable, Current 1.12M USD +129%
Employee-related Liabilities, Current 265K USD
Accrued Liabilities, Current 404K USD -48.7%
Liabilities, Current 2.03M USD +14.9%
Operating Lease, Liability, Noncurrent 775K USD -36%
Liabilities 2.81M USD -5.77%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD -100%
Retained Earnings (Accumulated Deficit) -343M USD -4.25%
Stockholders' Equity Attributable to Parent 6.66M USD -43.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.66M USD -43.4%
Liabilities and Equity 9.47M USD -35.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.98M USD +43.8%
Net Cash Provided by (Used in) Financing Activities 6.25M USD
Net Cash Provided by (Used in) Investing Activities 20K USD -97.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 14.4M shares +64.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.29M USD
Deferred Tax Assets, Valuation Allowance 2.98M USD +21.4%
Deferred Tax Assets, Gross 3.38M USD +14%
Operating Lease, Liability 1.29M USD -24.6%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -14M USD +22.6%
Lessee, Operating Lease, Liability, to be Paid 1.39M USD -26.9%
Property, Plant and Equipment, Gross 1.93M USD -11.5%
Operating Lease, Liability, Current 510K USD +3.03%
Lessee, Operating Lease, Liability, to be Paid, Year Two 460K USD -14.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 538K USD +2.87%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 106K USD -46.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 538K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 0 USD
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 460K USD 0%
Operating Lease, Payments 513K USD +18.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 70K USD +4.48%
Deferred Tax Assets, Net of Valuation Allowance 393K USD -22%
Share-based Payment Arrangement, Expense 1.19M USD -45.8%